Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared on X:
”Lipoprotein(a) [Lp(a)] is not just about coronary disease.
Robust genetic and population data confirm Lp(a) as a causal risk factor across multiple vascular beds.
- Peripheral Arterial Disease (PAD): Rising Lp(a) levels show a clear, stepwise association with PAD risk—up to ~3-fold higher risk at extreme concentrations.
- Major Adverse Limb Events (MALE): In patients with PAD, high Lp(a) markedly increases the risk of amputations and repeat revascularizations.
- Abdominal Aortic Aneurysm (AAA): Elevated Lp(a) is consistently associated with higher AAA risk, supported by Mendelian randomization.
- Inflammation matters—but doesn’t negate Lp(a) risk: Lp(a)-associated cardiovascular risk persists independently of hsCRP levels, in both primary and secondary prevention.
Clinical takeaway: Lp(a) identifies residual vascular risk beyond LDL-C and traditional factors—supporting routine measurement and future targeted therapy.
Phase 3 Lp(a)-lowering outcome trials may redefine prevention across coronary and non-coronary vascular disease.
Open Access here.
Article:Lipoprotein(a) in cardiovascular disease with focus on peripheral arterial disease, major adverse limb events, abdominal aortic aneurysms and interaction with low-grade inflammation
Authors: Peter E. Thomas, Signe Vedel-Krogh, Pia R. Kamstrup, Børge G. Nordestgaard
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India
-
Oct 20, 2026, 03:31Zena Vexler: Targeting Neutrophil Elastase and NETosis to Mitigate Infection-Triggered Childhood Stroke
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development